Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGR
2276
CBRE Global Real Estate Income Fund
IGR
$709M
| $5.25M | ﹤0.01% |
799,471
-192,387
| -19% | -$1.14M |
|
2277
Stratasys
SSYS
$760M
| $5.25M | ﹤0.01% |
631,872
+162,640
| +35% | +$1.28M |
|
2278
Columbia Sportswear
COLM
$2.93B
| $5.24M | ﹤0.01% |
63,022
+17,528
| +39% | +$1.41M |
|
2279
Global Net Lease
GNL
$1.91B
| $5.24M | ﹤0.01% |
622,338
-26,267
| -4% | -$220K |
|
|
HPS
2280
John Hancock Preferred Income Fund III
HPS
$458M
| $5.24M | ﹤0.01% |
303,775
-20,065
| -6% | -$326K |
|
|
BSJP
2281
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $5.24M | ﹤0.01% |
226,440
+60,967
| +37% | +$1.4M |
|
2282
Iovance Biotherapeutics
IOVA
$2.77B
| $5.24M | ﹤0.01% |
557,534
+529,535
| +1,891% | +$5.02M |
|
2283
Scholastic
SCHL
$753M
| $5.23M | ﹤0.01% |
163,324
-3,436
| -2% | -$110K |
|
2284
White Mountains Insurance
WTM
$5.3B
| $5.22M | ﹤0.01% |
3,079
-6
| -0.2% | -$10.5K |
|
2285
StoneCo
STNE
$2.69B
| $5.22M | ﹤0.01% |
463,700
+26,217
| +6% | +$334K |
|
2286
Global X Silver Miners ETF NEW
SIL
$4.47B
| $5.22M | ﹤0.01% |
148,014
+1,227
| +0.8% | +$40.9K |
|
2287
UiPath
PATH
$7.25B
| $5.21M | ﹤0.01% |
407,205
+161,273
| +66% | +$1.97M |
|
2288
Antero Midstream
AM
$10.2B
| $5.21M | ﹤0.01% |
346,315
-131,598
| -28% | -$1.92M |
|
2289
Invesco AI and Next Gen Software ETF
IGPT
$1.2B
| $5.2M | ﹤0.01% |
114,236
-23,134
| -17% | -$1.03M |
|
2290
Wolverine World Wide
WWW
$1.56B
| $5.19M | ﹤0.01% |
298,021
+64,474
| +28% | +$892K |
|
|
STEL
2291
DELISTED
Stellar Bancorp
STEL
| $5.19M | ﹤0.01% |
200,327
-21,018
| -9% | -$540K |
|
2292
Virtus Investment Partners
VRTS
$1.09B
| $5.17M | ﹤0.01% |
24,693
-1,170
| -5% | -$251K |
|
|
INVX
2293
Innovex International
INVX
$2.15B
| $5.17M | ﹤0.01% |
351,930
+6,263
| +2% | +$101K |
|
2294
RxSight
RXST
$253M
| $5.16M | ﹤0.01% |
104,441
+61,034
| +141% | +$3.13M |
|
2295
International Seaways
INSW
$4.61B
| $5.13M | ﹤0.01% |
99,402
+68,166
| +218% | +$3.59M |
|
2296
iShares New York Muni Bond ETF
NYF
$1.39B
| $5.11M | ﹤0.01% |
94,025
+912
| +1% | +$49.2K |
|
2297
NBT Bancorp
NBTB
$2.75B
| $5.1M | ﹤0.01% |
115,367
-10,123
| -8% | -$457K |
|
|
BCAX
2298
Bicara Therapeutics
BCAX
$1.81B
| $5.09M | ﹤0.01% |
+200,000
| New | +$5.1M |
|
2299
First Commonwealth Financial
FCF
$2.17B
| $5.09M | ﹤0.01% |
296,838
-20,120
| -6% | -$330K |
|
2300
Omnicell
OMCL
$1.65B
| $5.08M | ﹤0.01% |
116,618
-12,473
| -10% | -$470K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.